2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
19
Myofibroma
4
Menorrhagia
4
Myoma
3
Infertility
3
Adenomyosis
2
Sexual Dysfunction, Physiological
1
Pregnancy Complications
1
Polyps
1
Pelvic Pain
1
Lower Urinary Tract Symptoms
1
Hemorrhage
1
Fibroma
1
Endometriosis
1
Dysmenorrhea
1
Blood Loss, Surgical
1
Agnosia
1
Interventions
Colonoscopy
8
Endoscopy
3
Narrow Band Imaging
2
Eicosapentaenoic Acid
2
eicosapentaenoic acid ethyl ester
1
Uterine Myomectomy
1
Ursodeoxycholic Acid
1
Telemedicine
1
Suppositories
1
Sennosides
1
Selenium
1
Restraint, Physical
1
Radiotherapy
1
Propofol
1
Polyethylene Glycols
1
Ofloxacin
1
Midazolam
1
Metoclopramide
1
Methods
1
Folic Acid
1
Fentanyl
1
Fatty Acids, Omega-3
1
Everolimus
1
Erythromycin
1
Endoscopic Mucosal Resection
1
Endomet
1
Doxycycline
1
Docosahexaenoic Acids
1
Diet, Fat-Restricted
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polyps
×
Uterine Myomectomy
×
Clear all
NCT01152112
2017-09-13
HOME
Hologic, Inc.
Phase NA
Completed
74 enrolled
5 charts